Tag: Sinovac

Ping: Isyu sa Sinovac, Sana Naturuan ang Vaccine Officials na Maging Matapat

Sana naging instrumento ang kontrobersya sa Sinovac para matuto ng seryosong aral sa katapatan at walang ikinukubling transaksyon ang mga opisyales na nangangasiwa sa bakuna laban sa COVID-19.

Binigyang diin ito ni Senador Panfilo Lacson, kasabay ng pagsasabing hindi sana natuon sa Sinovac ang atensiyon ng Senado kung hindi nagpatumpik-tumpik ang mga opisyal.

“If they had been more forthright and honest in their responses in our first hearing, hindi mafo-focus sa Sinovac,” banggit ni Lacson sa panayam sa ANC.

Ayon pa sa mambabatas, palagiang handa ang dalawang kapulungan ng Kongreso na makipagtulungan sa ehekutibo kaya nararapat lamang na malaman din nila kung paano ginugugol ang mga pondong kanilang inaaprubahan.

“When the Senate hearings raised more questions than answers about Sinovac, our officials were both tongue-tied and stuttering, leaving us with a string of flip-flopping pronouncements,” bahagi ng privilege speech ni Lacson nitong Lunes.

Related: Lacson Hopes Vaccine Officials Learned Hard Lesson on Transparency
Continue reading “Ping: Isyu sa Sinovac, Sana Naturuan ang Vaccine Officials na Maging Matapat”

Lacson Hopes Vaccine Officials Learned Hard Lesson on Transparency

While there is still a long way to go as far as the government’s vaccination efforts are concerned, the controversy involving COVID-19 vaccines from Sinovac should be a hard lesson on honesty and transparency for officials in the program, Sen. Panfilo M. Lacson said Tuesday.

Lacson said that had the officials been forthright about the conditions of negotiations with Sinovac early on, there would have been no speculations or suspicions about the matter.

“If they had been more forthright and honest in their responses in our first hearing, hindi mafo-focus sa Sinovac,” he said in an interview on ANC, stressing that while Congress – the Senate and House of Representatives – are willing partners of the executive department, in return, lawmakers “need to be informed also what happened to the appropriations we gave you.”

“When the Senate hearings raised more questions than answers about Sinovac, our officials were both tongue-tied and stuttering, leaving us with a string of flip-flopping pronouncements,” Lacson noted in his privilege speech on the issue Monday.

Related: Ping: Isyu sa Sinovac, Sana Naturuan ang Vaccine Officials na Maging Matapat
Continue reading “Lacson Hopes Vaccine Officials Learned Hard Lesson on Transparency”

Privilege Speech on the National Vaccination Program

Mr. President, distinguished colleagues, I rise before you on a matter of collective and personal privilege.

Looking back to last week’s Committee of the Whole 2-day hearings, I couldn’t help but think that we’ve been had. Instead of having the information needed to aid us in our legislative work mainly because some people in the panel of our resource persons who are in charge of the vaccine program were not forthright and honest in their responses to the questions raised by the members of this august chamber.

Nevertheless, we find comfort from the wise words of Winston Churchill, who said and I quote: “Truth is incontrovertible, malice may attack it and ignorance may deride it, but, in the end, there it is.”

At the center of the firestorm that had almost consumed the two-day long hearings and had consumed us the most was the Sinovac vaccine for a number of reasons.

Continue reading “Privilege Speech on the National Vaccination Program”

Ping: Presyo ng Sinovac sa Pilipinas, Nangangamoy Katiwalian

Nangangamoy ‘tong-pats’ ang lumulutang na presyo ng bakuna ng Sinovac sa Pilipinas, kumpara sa presyo nito sa ibang bansa.

Ayon kay Senador Panfilo Lacson, ito ay kung pagbabatayan ang $5 kada turok na presyo sa ibang mga bansang naunang nakipagtransaksyon sa kumpanya para masigurado ang suplay at sa $38 (mahigit P1,800) per dose na ibinabalitang presyo sa Pilipinas.

Pero ayon kay Lacson, kung sakali mang totoo na ang sinabi ni Presidential Spokesperson Harry Roque Jr. na P650 kada turok ang magiging presyuhan sa bansa, ibig sabihin nito ay nagawa ng Senado ang obligasyon nito para sa makatuwirang presyo ng bakuna.

“If it’s true that government is now dropping the price of Sinovac vaccine from P1,847.25 per dose to only P650, the Senate has probably done our share to save our people billions of pesos in the country’s vaccination program. Netizens can pat themselves on the back,” paliwanag pa ni Lacson sa kanyang Twitter account.

Related: Lacson: Differences in Sinovac Prices Smack of Corruption
Continue reading “Ping: Presyo ng Sinovac sa Pilipinas, Nangangamoy Katiwalian”

Lacson: Differences in Sinovac Prices Smack of Corruption

Sharp differences in the prices of Sinovac vaccines in the Philippines and elsewhere may smack of corruption, Sen. Panfilo M. Lacson said Sunday.

Lacson noted that while Sinovac’s product may cost as little as $5 per dose, it may cost as much as a whopping $38 (more than P1,800) in the Philippines.

But Lacson said that if it is true the government is dropping the price of Sinovac vaccines to only P650 per dose, the Senate may have done its share to save billions of pesos in the government’s vaccination efforts.

“If it’s true that government is now dropping the price of Sinovac vaccine from P1,847.25 per dose to only P650, the Senate has probably done our share to save our people billions of pesos in the country’s vaccination program. Netizens can pat themselves on the back,” he said on his Twitter account.

Related: Ping: Presyo ng Sinovac sa Pilipinas, Nangangamoy Katiwalian
Continue reading “Lacson: Differences in Sinovac Prices Smack of Corruption”

Walang Pulitika sa Pagdinig na Ito: Second Senate Hearing on COVID Vaccination

At the second hearing of the Senate Committee of the Whole on the government’s vaccination efforts, Sen. Lacson debunked insinuations of politics in the hearings.

Continue reading “Walang Pulitika sa Pagdinig na Ito: Second Senate Hearing on COVID Vaccination”

Ping: Gobyerno May “Chosen One” Bakuna Na

Malinaw na malinaw ang mga senyales na may “chosen one” na bakuna laban sa COVID-19 ang gobyerno, sa kabila ng kawalan pa ng Emergency Use Authorization (EUA) sa kahit na anong kumpanyang gumagawa nito.

Ayon kay Senador Panfilo Lacson, ang binabanggit ng gobyerno na Sinovac lamang ang puwedeng magamit hanggang sa Hunyo ay nagpapatunay ng pagkakaroon na ng “chosen one” na bakuna.

“Can somebody explain why preference is given to the second most expensive vaccine, has lower efficacy, a record of suspended clinical trials and has not even applied for Emergency Use Authorization (EUA) over other vaccines that cost much less, more efficacious and are about to be granted their EUAs?” banggit ni Lacson sa Twitter.

Mas makatuwiran umano para sa mga Pinoy kung ang pagtrato ng gobyerno sa Sinovac ay gagawin din sa mga bakuna ng ibang bansa na di-hamak na mas epektibo at mas mababa ang presyo, ayon sa mambabatas.

“That said, the national government should expedite the procurement of all qualified and available vaccines. To borrow Secretary Harry Roque Jr.’s words, it should not be choosy in buying vaccines,” diin ni Lacson.

Related: Why Choosy? Lacson Scores Sinovac’s 5-Month Headway
Continue reading “Ping: Gobyerno May “Chosen One” Bakuna Na”

Why Choosy? Lacson Scores Sinovac’s 5-Month Headway

After telling ordinary Filipinos not to be choosy in getting their COVID vaccines, the government should apply the same line in expediting the procurement of all qualified and available vaccines, Sen. Panfilo M. Lacson said Wednesday.

Lacson noted the availability of only Sinovac until June, as well as the replies of officials at Monday’s Senate hearing, indicate China-based Sinovac is the “chosen one.”

“Can somebody explain why preference is given to the second most expensive vaccine, has lower efficacy, a record of suspended clinical trials and has not even applied for Emergency Use Authorization (EUA) over other vaccines that cost much less, more efficacious and are about to be granted their EUAs?” Lacson asked on Twitter.

“That said, the national government should expedite the procurement of all qualified and available vaccines. To borrow Secretary Harry Roque Jr.’s words, it should not be choosy in buying vaccines,” he added.

Related: Ping: Gobyerno May “Chosen One” Bakuna Na
Continue reading “Why Choosy? Lacson Scores Sinovac’s 5-Month Headway”

On the (Lack of) Choices for Vaccines

It’s not fair to say that Filipinos cannot choose their vaccines, at least from those made available by the government.

It’s bad enough that the national government virtually controls which brand/s of vaccines to procure. Pati ba naman ang pagpili kung ano ituturok sa braso ng mga Pilipino, hindi pa rin pwede mamili ang Pilipino?

Bakit ko naman pipiliin ang brand na 50% lang ang efficacy at wala man lang application for Emergency Use Authorization (EUA), against other brands with 79% and/or 95% efficacy and have pending EUA approval from the Food and Drug Administration?

Having said that, we can only pray and hope that the Inter-Agency Task Force on Emerging Infectious Diseases and the Department of Health properly implement the vaccination plan they laid out during our Senate hearing Monday.

While the plan may sound good, the difference is in the implementation – the reaction and responses to emergencies. Without proper execution, a plan no matter how good it is written and presented, won’t mean anything.

*****

‘Wala bang Sense of Urgency?’ Senate Hearing on COVID Vaccination

At the first hearing of the Senate Committee of the Whole on the government’s vaccination efforts, Sen. Lacson detailed how incompetence and lack of urgency slowed down the government’s efforts to procure COVID vaccines.

MORE DETAILS:
Continue reading “‘Wala bang Sense of Urgency?’ Senate Hearing on COVID Vaccination”